SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-209934
Filing Date
2012-05-04
Accepted
2012-05-04 06:23:08
Documents
12
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d335104d10q.htm 10-Q 579421
2 SUBLICENSE AGREEMENT d335104dex101.htm EX-10.1 309272
3 CERTIFICATION BY PRINCIPAL EXECUTIVE OFFICER d335104dex311.htm EX-31.1 7091
4 CERTIFICATION BY PRINCIPAL FINANCIAL OFFICER d335104dex312.htm EX-31.2 7151
5 CERTIFICATION BY PRINCIPAL EXECUTIVE OFFICER d335104dex321.htm EX-32.1 4122
6 CERTIFICATION BY PRINCIPAL FINANCIAL OFFICER d335104dex322.htm EX-32.2 4124
  Complete submission text file 0001193125-12-209934.txt   2914262

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT lgnd-20120331.xml EX-101.INS 334728
8 XBRL TAXONOMY EXTENSION SCHEMA lgnd-20120331.xsd EX-101.SCH 14392
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lgnd-20120331_cal.xml EX-101.CAL 54872
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lgnd-20120331_def.xml EX-101.DEF 19526
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE lgnd-20120331_lab.xml EX-101.LAB 152510
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lgnd-20120331_pre.xml EX-101.PRE 98310
Mailing Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037
Business Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 12811828
SIC: 2834 Pharmaceutical Preparations